Life sciences companies remain a leading driver of commercial real estate in New Jersey, accounting for more than a third of all office leases during the first half of 2023 and fueling a pipeline of deals for lab and manufacturing space.
Johnson & Johnson’s highly anticipated consumer health spinoff is leasing 290,000 square feet of office and laboratory space in Summit, in a deal that will activate a campus recently acquired by Onyx Equities.
One of the state’s newest apartment communities is not along the Hudson River or a mass transit line, but on the grounds of a historic castle built by a founding father of Johnson & Johnson.
